Clinical Trial Update: Polypill Strategy for Heart Failure With Reduced Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 trial update on a polypill strategy for heart failure with reduced ejection fraction; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Polypill strategy (investigational)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Heart Failure | Phase 2 | Status: COMPLETED